Heteroaryl substituted pyridines and methods of use
US-10138227-B2 · Nov 27, 2018 · US
This page is not indexed by search engines while we improve data quality.
Abbvie Sarl patents in 2018
Abbvie Sarl was listed as an assignee on 12 patent publications in 2018.
| Metric | Value |
|---|---|
| Company | Abbvie Sarl |
| Year | 2018 |
| Patents | 12 |
Patents
Representative publications for Abbvie Sarl in 2018.
Heteroaryl substituted pyridines and methods of use
US-10138227-B2 · Nov 27, 2018 · US
Compounds for treatment of cystic fibrosis
US-10130622-B2 · Nov 20, 2018 · US
Compounds for treatment of cystic fibrosis
US-10130622-B2 · Nov 20, 2018 · US
Modulators of cystic fibrosis transmembrane conductance regulator protein
US-10118916-B2 · Nov 6, 2018 · US
Top CPC classifications
Most common classification codes for Abbvie Sarl in 2018.
| CPC | Patents |
|---|---|
| A61P11/00 | 16 |
| A61K45/06 | 11 |
| A61P43/00 | 10 |
| A61K31/4545 | 6 |
| A61P1/18 | 6 |
Related pages
Navigate to parent entity pages.